Single-cell RNA sequencing reveals tissue architecture in small cell carcinoma of the ovary, hypercalcemic type

doi:10.19401/j.cnki.1007-3639.2022.11.004

Abstract

Abstract:

Background and purpose: Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a highly malignant, extremely rare primary undifferentiated ovarian cancer. This study aimed to reveal the tumor microenvironment and cellular and molecular characteristics of SCCOHT, and to explore potential drug targets. Methods: We collected recurrent pelvic lesions from one patient with SCCOHT, and applied single-cell RNA sequencing (scRNA-seq) to explore key cell subsets and potential drug targets. We further verified them at the cytological level. Results: There were four cell subsets and twelve cell subclusters of induced pluripotent stem cell (iPSC), neural Schwann cells, neuroepithelial cells and macrophages in the recurrent lesions of SCCOHT. The expression of genes significantly up-regulated by iPSC cell subgroups were mainly concentrated in cell cycle regulation, among which PLK1 was the most significantly up-regulated gene. PLK1 protein was positively expressed in SCCOHT tissue sections and increased in SCCOHT cell lines. Conclusion: It was revealed that the tumor microenvironment of SCCOHT was composed of iPSCs, neural Schwann cells, neuroepithelial cells and macrophages. The key cell subsets of iPSCs were identified, and PLK1 gene was found as a potential therapeutic target.

Key words: Small cell carcinoma of the ovary, hypercalcemic type, Single-cell RNA sequencing, PLK1

CLC Number:

R737.31

KANG Mingyi, GAO Yi, XU Jing, KANG Yu, XU Congjian. Single-cell RNA sequencing reveals tissue architecture in small cell carcinoma of the ovary, hypercalcemic type[J]. China Oncology, 2022, 32(11): 1065-1073.

Figures/Tables 7

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

Fig. 6

Fig. 7

References 21

[1]	汪璟, 刘浏, 李可, 等. 卵巢高钙血症型小细胞癌研究进展[J]. 中国实用妇科与产科杂志, 2019, 35(10): 1166-70.
[2]	WANG J, LIU L, LI K, et al. Research progress of small cell carcinoma of ovary with hypercalcemia[J]. Chin J Pract Gynecol Obstet, 2019, 35(10): 1166-70.
[3]	YOUNG R H, OLIVA E, SCULLY R E. Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases[J]. Am J Surg Pathol, 1994, 18(11): 1102-1116. pmid: 7943531
[4]	徐燕宁, 刘易欣, 陈凌. 卵巢高钙血症型小细胞癌的研究进展[J]. 国际妇产科学杂志, 2021, 48(5): 548-552.
[5]	XU Y N, LIU Y X, CHEN L. Advances in small cell carcinoma of the ovary-hypercalcemic type[J]. J Int Obstet Gynecol, 2021, 48(5): 548-552.
[6]	BELL E H, CHAKRABORTY A R, MO X K, et al. SMARCA4/BRG1 is a novel prognostic biomarker predictive of cisplatin-based chemotherapy outcomes in resected non-small cell lung cancer[J]. Clin Cancer Res, 2016, 22(10): 2396-2404. doi: 10.1158/1078-0432.CCR-15-1468 pmid: 26671993
[7]	TUMEH P C, HARVIEW C L, YEARLEY J H, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance[J]. Nature, 2014, 515(7528): 568-571. doi: 10.1038/nature13954
[8]	WANG Y M, CHEN S Y, COLBORNE S, et al. Histone deacetylase inhibitors synergize with catalytic inhibitors of EZH2 to exhibit antitumor activity in small cell carcinoma of the ovary, hypercalcemic type[J]. Mol Cancer Ther, 2018, 17(12): 2767-2779. doi: 10.1158/1535-7163.MCT-18-0348 pmid: 30232145
[9]	LANG J D, HENDRICKS W P D, ORLANDO K A, et al. Ponatinib shows potent antitumor activity in small cell carcinoma of the ovary hypercalcemic type (SCCOHT) through multikinase inhibition[J]. Clin Cancer Res, 2018, 24(8): 1932-1943. doi: 10.1158/1078-0432.CCR-17-1928 pmid: 29440177
[10]	XUE Y B, MEEHAN B, MACDONALD E, et al. CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary[J]. Nat Commun, 2019, 10: 558. doi: 10.1038/s41467-018-06958-9 pmid: 30718512
[11]	KARNEZIS A N, CHEN S Y, CHOW C, et al. Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines[J]. Gynecol Oncol, 2021, 160(2): 568-578. doi: 10.1016/j.ygyno.2020.12.004 pmid: 33328126
[12]	ANGERER P, HAGHVERDI L, BÜTTNER M, et al. Destiny: diffusion maps for large-scale single-cell data in R[J]. Bioinformatics, 2016, 32(8): 1241-1243. doi: 10.1093/bioinformatics/btv715 pmid: 26668002
[13]	LEVINE J H, SIMONDS E F, BENDALL S C, et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis[J]. Cell, 2015, 162(1): 184-197. doi: 10.1016/j.cell.2015.05.047 pmid: 26095251
[14]	BACAKOVA L, ZARUBOVA J, TRAVNICKOVA M, et al. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells-a review[J]. Biotechnol Adv, 2018, 36(4): 1111-1126. doi: 10.1016/j.biotechadv.2018.03.011
[15]	OHNUKI M, TAKAHASHI K. Present and future challenges of induced pluripotent stem cells[J]. Philos Trans R Soc Lond B Biol Sci, 2015, 370(1680): 20140367. doi: 10.1098/rstb.2014.0367
[16]	WITKOWSKI L, CARROT-ZHANG J, ALBRECHT S, et al. Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type[J]. Nat Genet, 2014, 46(5): 438-443. doi: 10.1038/ng.2931 pmid: 24658002
[17]	HARRISON M L, HOSKINS P, DU BOIS A, et al. Small cell of the ovary, hypercalcemic type: analysis of combined experience and recommendation for management. A GCIG study[J]. Gynecol Oncol, 2006, 100(2): 233-238. doi: 10.1016/j.ygyno.2005.10.024
[18]	JELINIC P, RICCA J, VAN OUDENHOVE E, et al. Immune-active microenvironment in small cell carcinoma of the ovary, hypercalcemic type: rationale for immune checkpoint blockade[J]. J Natl Cancer Inst, 2018, 110(7): 787-790. doi: 10.1093/jnci/djx277 pmid: 29365144
[19]	NASSAR D, BLANPAIN C. Cancer stem cells: basic concepts and therapeutic implications[J]. Annu Rev Pathol, 2016, 11: 47-76. doi: 10.1146/annurev-pathol-012615-044438 pmid: 27193450
[20]	HAMANAKA R, MALOID S, SMITH M R, et al. Cloning and characterization of human and murine homologues of the drosophila polo serine-threonine kinase[J]. Cell Growth Differ, 1994, 5(3): 249-257. pmid: 8018557
[21]	TONG C, FAN H Y, LIAN L, et al. Polo-like kinase-1 is a pivotal regulator of microtubule assembly during mouse oocyte meiotic maturation, fertilization, and early embryonic mitosis[J]. Biol Reprod, 2002, 67(2): 546-554. doi: 10.1095/biolreprod67.2.546 pmid: 12135894